GLP / cGMP Contract Laboratory Services
Visit Intertek during CPhI Booth 3J90. Our innovative pharmaceutical services can expedite product development and support manufacture. Our global network of industry experts and GLP/GMP laboratories are ready to help you.
Visit Intertek during CPhIBooth 3J90
With Intertek as your partner, you can trust us to provide a single source solution with expertise that fits your unique needs for both pharmaceuticals and biopharmaceuticals. Over the last 20 years our network of Good Laboratory Practice (GLP) and Good Manufacturing Practice (cGMP) laboratories has provided high quality technical services for some of the world's largest and most innovative pharmaceutical companies.
GMP and CMC Laboratory Services
We provide regulatory-driven, phase-appropriate laboratory services in support of CMC programs seeing you through preformulation, formulation and product release. Our capabilities include method development and validation, analysis, stability studies, extractables and leachables, cGMP quality control testing and cGMP batch release testing.
Bioanalysis Services
During preclinical and clinical development, our biomarker and bioanalysis experts design and manage strategic work programs. Our expertise and industry insight aims to supply the data you need as quickly and efficiently as possible.
Regulatory and Toxicology Consulting
From discovery to commercialisation, our pharmaceutical regulatory consultants provide a fast-track and cost-effective approach to allow you to gain market access.
Pharmaceutical Auditing.
Through our shared audit programs, delivered by our global network of specialist auditors, you can benefit from rapid implementation, easier access to audit sites and potential cost savings.
Contact Details:
Intertek Pharmaceutical Services
Website: www.intertek.com/pharmaceutical/
E-mail: pharma.services@intertek.com
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
